Skip to content

Impact of Health Support Interventions on Quality of Life and Clinical Outcomes in Patients with Thoracic Malignancies Receiving Neoadjuvant Therapy: A Prospective Cohort Study

Impact of Health Support Interventions on Quality of Life and Clinical Outcomes in Patients with Thoracic Malignancies Receiving Neoadjuvant Therapy: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125765
Enrollment
Unknown
Registered
2026-05-31
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally advanced esophageal squamous cell carcinoma and non-small cell lung cancer

Interventions

Intervention Group:Comprehensive Health Support Intervention

Sponsors

Hunan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 75 years; 2.Pathologically confirmed esophageal squamous cell carcinoma or non-small cell lung cancer, scheduled to undergo radical surgery after neoadjuvant chemo-immunotherapy; 3.Able to read and understand the study materials and complete questionnaires independently; 4.Able to comply with study procedures, follow-up, assessments, and interventions; 5.Normal limb function and considered safe for preoperative and postoperative exercise intervention after cardiopulmonary evaluation; 6.No obvious exercise limitation and suitable for individualized exercise intervention, including aerobic and resistance training; 7.Voluntarily agree to participate and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients unsuitable for body composition analysis, such as those with pacemakers, metallic implants, or postoperative drainage tubes; 2.Severe or uncontrolled systemic diseases that may significantly affect the risk-benefit balance; 3.Pregnant or breastfeeding women; 4.Cognitive impairment or psychiatric abnormalities preventing study participation and follow-up; 5.Metastasis to other major organs making R0 resection impossible; 6.Concomitant malignancy at another site; 7.Severe postoperative complications making exercise intervention intolerable; 8.Failure to complete the exercise program/intervention due to poor compliance or exercise-related adverse reactions; 9.Other conditions considered unsuitable by the investigator. 10. Individuals with severe cardiovascular, respiratory, or other underlying diseases, who are assessed as unsuitable for preoperative or postoperative exercise intervention;

Design outcomes

Primary

MeasureTime frame
Postoperative complication rate;

Secondary

MeasureTime frame
Cardiopulmonary function;

Countries

China

Contacts

Public ContactYang De Song

Hunan Cancer Hospital

yangdesong@hnca.org.cn+86 731 8976 2192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026